These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39268705)

  • 21. A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii.
    Zhang MY; Li S; Wang CY; Zhang ZX; Han YL; Liu XQ; Cheng J; Zhou XY; Zhang YX
    J Antimicrob Chemother; 2024 Aug; 79(8):1951-1961. PubMed ID: 38863365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Defense Peptide Mimicking Peptide Polymer Exerting Fast, Broad Spectrum, and Potent Activities toward Clinically Isolated Multidrug-Resistant Bacteria.
    Chen S; Shao X; Xiao X; Dai Y; Wang Y; Xie J; Jiang W; Sun Y; Cong Z; Qiao Z; Zhang H; Liu L; Zhang Q; Zhang W; Zheng L; Yu B; Chen M; Cui W; Fei J; Liu R
    ACS Infect Dis; 2020 Mar; 6(3):479-488. PubMed ID: 31922723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus.
    Hincapié O; Giraldo P; Orduz S
    Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
    De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
    J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of cell selective α/β-diastereomeric peptidomimetic with potent in vivo antibacterial activity against methicillin resistant S. Aureus.
    Dewangan RP; Bisht GS; Singh VP; Yar MS; Pasha S
    Bioorg Chem; 2018 Feb; 76():538-547. PubMed ID: 29310083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Modification of Lipopolysaccharide Conferred by
    Liu YY; Chandler CE; Leung LM; McElheny CL; Mettus RT; Shanks RMQ; Liu JH; Goodlett DR; Ernst RK; Doi Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373195
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lee B; Yan J; Ulhaq A; Miller S; Seo W; Lu P; She R; Spellberg B; Luna B
    mSphere; 2021 Dec; 6(6):e0092021. PubMed ID: 34817233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multimodel regime for evaluating effectiveness of antimicrobial wound care products in microbial biofilms.
    Stoffel JJ; Kohler Riedi PL; Hadj Romdhane B
    Wound Repair Regen; 2020 Jul; 28(4):438-447. PubMed ID: 32175636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.
    Irazazabal LN; Porto WF; Ribeiro SM; Casale S; Humblot V; Ladram A; Franco OL
    Biochim Biophys Acta; 2016 Nov; 1858(11):2699-2708. PubMed ID: 27423268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials.
    Taati Moghadam M; Khoshbayan A; Chegini Z; Farahani I; Shariati A
    Drug Des Devel Ther; 2020; 14():1867-1883. PubMed ID: 32523333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule anion transporters display in vitro antimicrobial activity against clinically relevant bacterial strains.
    Carreira-Barral I; Rumbo C; Mielczarek M; Alonso-Carrillo D; Herran E; Pastor M; Del Pozo A; García-Valverde M; Quesada R
    Chem Commun (Camb); 2019 Aug; 55(68):10080-10083. PubMed ID: 31380526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional Antimicrobial Nanofiber Dressings Containing ε-Polylysine for the Eradication of Bacterial Bioburden and Promotion of Wound Healing in Critically Colonized Wounds.
    Mayandi V; Wen Choong AC; Dhand C; Lim FP; Aung TT; Sriram H; Dwivedi N; Periayah MH; Sridhar S; Fazil MHUT; Goh ETL; Orive G; W Beuerman R; Barkham TMS; Loh XJ; Liang ZX; Barathi VA; Ramakrishna S; Chong SJ; Verma NK; Lakshminarayanan R
    ACS Appl Mater Interfaces; 2020 Apr; 12(14):15989-16005. PubMed ID: 32172559
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Escobar-Salom M; Barceló IM; Rojo-Molinero E; Jordana-Lluch E; Cabot G; Oliver A; Juan C
    Microbiol Spectr; 2024 Apr; 12(4):e0035824. PubMed ID: 38441982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.